Samsung Biologics Co.,Ltd. technical analysis
Technical analysis of Samsung Biologics Co.,Ltd. (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
What is Samsung Biologics Co.,Ltd.
Samsung Biologics Co., Ltd. is a company headquartered in Incheon, South Korea, founded in 2011, operating in the biopharmaceutical sector. The company is engaged in the manufacturing, commercialization, and distribution of biopharmaceutical products in South Korea, Europe, the United States, and internationally. Its services include cell line development, GMP and non-GMP manufacturing, aseptic filling, lyophilization, cold chain storage, and analytical quality testing.
Description generated automatically from public sources; it may be inaccurate or out of date.
Samsung Biologics Co.,Ltd.: latest session data
Closing values for September 3, 2026, computed on the last 12 months of prices.
Moving averages
21 sessions
1,543,285.71
−6.24%
50 sessions
1,472,820.00
−1.75%
200 sessions
1,580,648.25
−8.46%
Session levels
s2
1,423,666.67
Support
s1
1,450,333.33
Support
pivot
1,477,666.67
Pivot
r1
1,504,333.33
Resistance
r2
1,531,666.67
Resistance
How to read it
In the September 3, 2026 session Samsung Biologics Co.,Ltd. closed lower at 1,447,000.00 , −2.03% versus the previous session.
The price sits below every moving average observed: −6.24% against the 21-session average, −1.75% against the 50 and −8.46% against the 200.
The 14-period RSI reads 41.5, in neutral territory.
MACD stands at 2,068.562 against a signal line at 19,453.729: the histogram is negative (−17,385.167).
ADX reads 16.4, indicating weak directionality.
Levels computed on the latest session place supports at 1,450,333.33 and 1,423,666.67 and resistances at 1,504,333.33 and 1,531,666.67 , around a pivot of 1,477,666.67.
The average daily range (ATR) is 56,696.325 , or 3.92% of price.
Turnover was 45.4K shares, 93% of the 20-session average.
Over the last twelve months the price ranged between 1,228,000.00 and 1,660,000.00 , and today stands −12.83% from the period high.
Measures computed on closing prices. They describe the past; they are not forecasts.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the 207940.KS analysis.
How Montbon’s technical analysis works
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
FAQ about Samsung Biologics Co.,Ltd.
How is a stock like Samsung Biologics analyzed technically?
Technical analysis of a stock like Samsung Biologics involves studying price charts and trading volumes over time, using tools such as moving averages, Bollinger Bands, and oscillators to identify trends and support or resistance levels. These tools help understand the historical price behavior, independently of the company's fundamentals.
Which technical indicators are commonly used to analyze healthcare sector stocks?
For healthcare sector stocks, as with other equities, commonly used indicators include the RSI (Relative Strength Index) to assess overbought or oversold conditions, MACD to identify momentum shifts, and moving averages to follow the trend direction. The choice of indicators depends on the observation timeframe and the analytical approach adopted.
On which timeframes should technical analysis of a listed stock be observed?
Technical analysis can be applied across multiple timeframes: daily or weekly charts are often used to identify medium-to-long-term trends, while 1-hour or 15-minute charts are used for shorter-term analysis. Combining multiple timeframes provides a more comprehensive view of price behavior.
Other tickers to analyse
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.